Intravenous caffeine may speed up the emergence from isoflurane anesthesia in healthy males without any apparent adverse effects, according to a study published in the journal Anesthesiology.
Robert Fong and his associates had previously reported that caffeine is able to accelerate emergence from anesthesia in rodents. They further conducted a single-centered, randomized, double-blind crossover study to test the hypothesis that caffeine accelerates the emergence from anesthesia in human.
The study included eight healthy males and each participant was anesthetized twice with 1.2% isoflurane for 1 h. During the final 10 min of each session, participants received an intravenous infusion of either caffeine citrate (15 mg/kg, equivalent to 7.5 mg/kg of caffeine base) or saline placebo.
The primary endpoint was the average difference in time to emergence after isoflurane discontinuation between caffeine and saline sessions. Secondary outcomes included the end-tidal isoflurane concentration at emergence, vital signs, and Bispectral Index values measured throughout anesthesia and emergence.
- The mean time to emergence with saline was 16.5 ± 3.9 (SD) min compared to 9.6 ± 5.1 (SD) min with caffeine, a difference of 6.9 min, a 42% reduction.
- Participants emerged at a higher expired isoflurane concentration, manifested more rapid return to baseline Bispectral Index values and were able to participate in psychomotor testing sooner when receiving caffeine.
- There were no statistically significant differences in vital signs with caffeine administration and caffeine-related adverse events.
The study concluded that IV caffeine is able to accelerate emergence from isoflurane anesthesia in healthy males without any apparent adverse effects.
For reference log on to https://doi.org/10.1097/aln.0000000000002367
Latest posts by Vinay Singh (see all)
- Impotence very common in childhood cancer survivors - October 18, 2018
- Trials establish efficacy of tretinoin lotion in acne - October 18, 2018
- Papaverin increases sensitivity of tumour cells to Radiotherapy - October 18, 2018